Literature DB >> 15579178

The effects of recombinant human thyrotropin, in normal subjects and patients with goitre.

Viveque Egsgaard Nielsen1, Steen Joop Bonnema, Laszlo Hegedüs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579178     DOI: 10.1111/j.1365-2265.2004.02134.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  5 in total

Review 1.  Non-surgical approach to the benign nodular goiter: new opportunities by recombinant human TSH-stimulated 131I-therapy.

Authors:  Steen Joop Bonnema; Søren Fast; Laszlo Hegedüs
Journal:  Endocrine       Date:  2011-10-05       Impact factor: 3.633

Review 2.  An outline concerning the potential use of recombinant human thyrotropin for improving radioiodine therapy of multinodular goiter.

Authors:  Geraldo Medeiros-Neto; Suemi Marui; Meyer Knobel
Journal:  Endocrine       Date:  2008-05-20       Impact factor: 3.633

3.  Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin.

Authors:  I G S Rubio; M N C Silva; M Knobel; R Romão; R Possato; E M M S Gebrin; C Buchpiguel; G Medeiros-Neto
Journal:  J Endocrinol Invest       Date:  2007 Jul-Aug       Impact factor: 4.256

4.  Radioiodine treatment for non-toxic goitre.

Authors:  Ulla Feldt-Rasmussen
Journal:  F1000 Med Rep       Date:  2009-09-14

5.  Familial Longevity is Associated with an Attenuated Thyroidal Response to Recombinant Human Thyroid Stimulating Hormone.

Authors:  Ana Zutinic; Hanno Pijl; Bart E Ballieux; Ferdinand Roelfsema; Rudi G J Westendorp; Gerard J Blauw; Diana van Heemst
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.